There were 872 press releases posted in the last 24 hours and 441,123 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
VistaGen Therapeutics Appoints Dr. Mark Wallace to Clinical Advisory Board to Advance AV-101 as a Potential Non-Opioid Treatment for Neuropathic Pain

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image